192 related articles for article (PubMed ID: 33932512)
1. Identification of the molecular targets and mechanisms of compound mylabris capsules for hepatocellular carcinoma treatment through network pharmacology and bioinformatics analysis.
Wei J; Ma L; Liu W; Wang Y; Shen C; Zhao X; Zhao C
J Ethnopharmacol; 2021 Aug; 276():114174. PubMed ID: 33932512
[TBL] [Abstract][Full Text] [Related]
2. Huanglian decoction suppresses the growth of hepatocellular carcinoma cells by reducing
Li M; Shang H; Wang T; Yang SQ; Li L
World J Gastroenterol; 2021 Mar; 27(10):939-958. PubMed ID: 33776365
[TBL] [Abstract][Full Text] [Related]
3. Systems Pharmacology-Based Identification of Mechanisms of Action of Bolbostemma paniculatum for the Treatment of Hepatocellular Carcinoma.
Wang LL; Liao C; Li XQ; Dai R; Ren QW; Shi HL; Wang XP; Feng XS; Chao X
Med Sci Monit; 2021 Jan; 27():e927624. PubMed ID: 33436534
[TBL] [Abstract][Full Text] [Related]
4. A Strategy based on Bioinformatics and Machine Learning Algorithms Reveals Potential Mechanisms of Shelian Capsule against Hepatocellular Carcinoma.
Zhou X; Tan F; Zhang S; Wang A; Zhang T
Curr Pharm Des; 2024; 30(5):377-405. PubMed ID: 38310567
[TBL] [Abstract][Full Text] [Related]
5. Da-Chai-Hu-Tang Formula inhibits the progression and metastasis in HepG2 cells through modulation of the PI3K/AKT/STAT3-induced cell cycle arrest and apoptosis.
Duan ZW; Liu Y; Zhang PP; Hu JY; Mo ZX; Liu WQ; Ma X; Zhou XH; Wang XH; Hu XH; Wei SL
J Ethnopharmacol; 2024 Sep; 331():118293. PubMed ID: 38705430
[TBL] [Abstract][Full Text] [Related]
6. A metabolic data-driven systems pharmacology strategy for decoding and validating the mechanism of Compound Kushen Injection against HCC.
Wang KX; Chen YP; Lu AP; Du GH; Qin XM; Guan DG; Gao L
J Ethnopharmacol; 2021 Jun; 274():114043. PubMed ID: 33753143
[TBL] [Abstract][Full Text] [Related]
7. Based on network pharmacology and experiments to explore the underlying mechanism of Mahonia bealei (Fortune) Carrière for treating alcoholic hepatocellular carcinoma.
Zhang N; Zhu Y; Zhang X; Yang K; Yang X; An M; Tian C; Li J
J Ethnopharmacol; 2024 Jan; 318(Pt A):116919. PubMed ID: 37453621
[TBL] [Abstract][Full Text] [Related]
8. An advanced network pharmacology study to explore the novel molecular mechanism of Compound Kushen Injection for treating hepatocellular carcinoma by bioinformatics and experimental verification.
Lu S; Meng Z; Tan Y; Wu C; Huang Z; Huang J; Fu C; Stalin A; Guo S; Liu X; You L; Li X; Zhang J; Zhou W; Zhang X; Wang M; Wu J
BMC Complement Med Ther; 2022 Mar; 22(1):54. PubMed ID: 35236335
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatic and experimental data decipher the pharmacological targets and mechanisms of plumbagin against hepatocellular carcinoma.
Zhou R; Wu K; Su M; Li R
Environ Toxicol Pharmacol; 2019 Aug; 70():103200. PubMed ID: 31158732
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of Codonopsis pilosula in inhibiting hepatocellular carcinoma growth and metastasis.
Li N; Yang C; Xia J; Wang W; Xiong W
Phytomedicine; 2024 Jun; 128():155338. PubMed ID: 38520835
[TBL] [Abstract][Full Text] [Related]
11. A systematic approach to decode the mechanism of Cornus in the treatment of hepatocellular carcinoma (HCC).
Shen HY; Li XQ; Fan WQ; Wang YW; Huang F; Wu JQ; Zhang W; Feng XS; Chao X
Eur J Pharmacol; 2021 Oct; 909():174405. PubMed ID: 34384755
[TBL] [Abstract][Full Text] [Related]
12. CDK1-PLK1/SGOL2/ANLN pathway mediating abnormal cell division in cell cycle may be a critical process in hepatocellular carcinoma.
Li L; Huang K; Zhao H; Chen B; Ye Q; Yue J
Cell Cycle; 2020 May; 19(10):1236-1252. PubMed ID: 32275843
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of hepatocellular carcinoma cell proliferation through regulation of the Cell Cycle, AGE-RAGE, and Leptin signaling pathways by a compound formulation comprised of andrographolide, wogonin, and oroxylin A derived from Andrographis Paniculata(Burm.f.) Nees.
Gao S; Tan H; Gang J
J Ethnopharmacol; 2024 Jul; 329():118001. PubMed ID: 38467318
[TBL] [Abstract][Full Text] [Related]
14. A systems biology-based investigation into the therapeutic effects of Gansui Banxia Tang on reversing the imbalanced network of hepatocellular carcinoma.
Zhang Y; Guo X; Wang D; Li R; Li X; Xu Y; Liu Z; Song Z; Lin Y; Li Z; Lin N
Sci Rep; 2014 Feb; 4():4154. PubMed ID: 24561634
[TBL] [Abstract][Full Text] [Related]
15. Exploring the effect of Gupi Xiaoji Prescription on hepatitis B virus-related liver cancer through network pharmacology and in vitro experiments.
Yu S; Gao W; Zeng P; Chen C; Zhang Z; Liu Z; Liu J
Biomed Pharmacother; 2021 Jul; 139():111612. PubMed ID: 33915505
[TBL] [Abstract][Full Text] [Related]
16. Cyclin-dependent kinase 1 as a potential target for lycorine against hepatocellular carcinoma.
Yin S; Yang S; Luo Y; Lu J; Hu G; Wang K; Shao Y; Zhou S; Koo S; Qiu Y; Wang T; Yu H
Biochem Pharmacol; 2021 Nov; 193():114806. PubMed ID: 34673013
[TBL] [Abstract][Full Text] [Related]
17. A network pharmacology-based investigation on the bioactive ingredients and molecular mechanisms of Gelsemium elegans Benth against colorectal cancer.
Que W; Chen M; Yang L; Zhang B; Zhao Z; Liu M; Cheng Y; Qiu H
BMC Complement Med Ther; 2021 Mar; 21(1):99. PubMed ID: 33743701
[TBL] [Abstract][Full Text] [Related]
18. Network pharmacology evaluation of the active ingredients and potential targets of XiaoLuoWan for application to uterine fibroids.
Yu Y; Yang F; Liu H
Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33196098
[TBL] [Abstract][Full Text] [Related]
19. Longikaurin A, a natural ent-kaurane, induces G2/M phase arrest via downregulation of Skp2 and apoptosis induction through ROS/JNK/c-Jun pathway in hepatocellular carcinoma cells.
Liao YJ; Bai HY; Li ZH; Zou J; Chen JW; Zheng F; Zhang JX; Mai SJ; Zeng MS; Sun HD; Pu JX; Xie D
Cell Death Dis; 2014 Mar; 5(3):e1137. PubMed ID: 24651440
[TBL] [Abstract][Full Text] [Related]
20. [CDK1, CCNB1 and NDC80 are associated with prognosis and progression of hepatitis B virus-associated hepatocellular carcinoma: a bioinformatic analysis].
Li Y; Wu D; Wei C; Yang X; Zhou S
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Oct; 41(10):1509-1518. PubMed ID: 34755666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
